{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:13:34Z","timestamp":1788480814988,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rbmo.2026.105784","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T14:50:45Z","timestamp":1779029445000},"page":"105784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Random start natural progesterone-primed ovarian stimulation (NPPOS) enables maximal flexibility: analysis of 1202 freeze-all cycles"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1402-0576","authenticated-orcid":false,"given":"Florence","family":"Vandierendonck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Biesbroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Dhaenens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Sofie","family":"Rottiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke Vanden","family":"Meerschaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Heindryckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Tilleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00eb","family":"De Roo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Stoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2026.105784_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2021.102080","article-title":"Ovarian stimulation for fertility preservation in women with cancer: A systematic review and meta-analysis comparing random and conventional starts","volume":"50","author":"Alexander","year":"2021","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105784_bib0002","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses","volume":"27","author":"Ata","year":"2020","journal-title":"Hum. Reprod. Updat."},{"key":"10.1016\/j.rbmo.2026.105784_bib0003","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0015-0282(03)00544-2","article-title":"A new model for ovarian follicular development during the human menstrual cycle","volume":"80","author":"Baerwald","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2026.105784_bib0004","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.fertnstert.2013.07.1992","article-title":"Effective method for emergency fertility preservation: random-start controlled ovarian stimulation","volume":"100","author":"Cakmak","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2026.105784_bib0005","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3389\/fendo.2019.00796","article-title":"Progestin versus Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.rbmo.2026.105784_bib0006","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/humrep\/dep291","article-title":"A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol","volume":"24","author":"Devroey","year":"2009","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105784_bib0007","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-Free Clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105784_bib0008","first-page":"hoaa009","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI","author":"Bosch","year":"2020","journal-title":"Hum. Reprod. Open"},{"key":"10.1016\/j.rbmo.2026.105784_bib0009","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/humrep\/der479","article-title":"Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome","volume":"27","author":"Gallot","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105784_bib0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/humrep\/deq361","article-title":"Serum anti-M\u00fcllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation","volume":"26","author":"Genro","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105784_bib0011","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3346\/jkms.2015.30.3.290","article-title":"Efficacy of Random-start Controlled Ovarian Stimulation in Cancer Patients","volume":"30","author":"Kim","year":"2014","journal-title":"J. Korean M\u00e9d. Sci."},{"key":"10.1016\/j.rbmo.2026.105784_bib0012","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2026.105784_bib0013","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.rbmo.2019.03.212","article-title":"Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?","volume":"39","author":"Marca","year":"2019","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2026.105784_bib0014","first-page":"211","article-title":"New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF","volume":"23","author":"Massin","year":"2017","journal-title":"Hum. Reprod. Updat."},{"key":"10.1016\/j.rbmo.2026.105784_bib0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mefs.2010.08.009","article-title":"The endocrine effects of multiple folliculogenesis","volume":"16","author":"Messinis","year":"2011","journal-title":"Middle East Fertil. Soc. J."},{"key":"10.1016\/j.rbmo.2026.105784_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2024.104121","article-title":"The dark side of random-start ovarian stimulation: ovarian hyperstimulation syndrome due to inadvertent pregnancy","volume":"49","author":"Semrl","year":"2024","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2026.105784_bib0017","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.rbmo.2018.07.006","article-title":"New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation","volume":"37","author":"Sighinolfi","year":"2018","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2026.105784_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2023.103337","article-title":"Random start ovarian stimulation before gonadotoxic therapies in women with cancer: a systematic review and meta-analysis","volume":"47","author":"S\u00f6nmezer","year":"2023","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2026.105784_bib0019","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/humrep\/den219","article-title":"Why do couples drop-out from IVF treatment? A prospective cohort study","volume":"23","author":"Verberg","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105784_bib0020","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/humrep\/deae047","article-title":"Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles","volume":"39","author":"Vidal","year":"2023","journal-title":"Hum. Reprod. (Oxf., Engl.)"},{"key":"10.1016\/j.rbmo.2026.105784_bib0021","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijgo.14903","article-title":"Outcomes and cost-effectiveness comparisons of progestin-primed ovarian stimulation, GnRH antagonist protocol, and luteal phase stimulation for fertility preservation","volume":"163","author":"Zhao","year":"2023","journal-title":"Int. J. Gynecol. Obstet."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648326003251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648326003251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:45:37Z","timestamp":1788479137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648326003251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1472648326003251"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2026.105784","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Random start natural progesterone-primed ovarian stimulation (NPPOS) enables maximal flexibility: analysis of 1202 freeze-all cycles","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2026.105784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105784"}}